FDA authorizes Pfizer vaccine for 5-11 age group. CDC will discuss further clinical recommendation.
Where: United States
The Facts
The US Food and Drug Administration(FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 in children 5-11 years of age.
The CDC Advisory Committee on Immunization Practices is expected to meet next week to discuss further clinical recommendations.
The Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 is a lower dose (10 micrograms) than that used for individuals aged 12 years and older.
Lee Savio Beers, president of the American Academy of Pediatrics, stated, “The American Academy of Pediatrics is encouraged that the US Food and Drug Administration has authorized a COVID-19 vaccine for children ages 5 to 11 after reviewing scientific data validating its safety and effectiveness.”
Only a few other countries, including China, have cleared the Covid-19 vaccine for children of this age group and younger.
Primary Sources
Direct, authoritative source material on this story.
Reference Articles
Articles Citable has ingested related to this story.
Reference Articles
Articles Citable has ingested related to this story.
Media Coverage
Why did we include this story
Most covered story by the media today
of articles referenced this story
Coverage by Media Outlet
Media outlets covering this story along with their positive or negative sentiment toward this story.
